BioHarvest Sciences Inc. Common Stock BHST
At closeNov 4, 2026, 4:00 PM EST
After hours · Nov 4, 4:00 PM ET
- YTD
- -71.87%
- 1 year
- -83.06%
- Market cap
- 33.10M
- Revenue (ttm)
- 19.13M
- Profit margin
- -84.84%
- EPS (ttm)
- -0.51
- Shares out
- 17.33M
- YTD return
- -71.87%
- 1-year return
- -83.06%
- Volume
- 9.72K
- Avg volume
- 35.95K
- Open
- 1.53
- Previous close
- 1.54
- Day's range
- 1.46 – 1.53
- 52-week range
- 1.37 – 9.25
- Beta
- 1.49
- Analysts
- Buy
- Price target
- 14.67 (+904.6%)
YTD -3.75 (-71.98%)
Key statistics
- Enterprise value
- 114.38M
- PEG ratio
- 0.00
- Price / sales
- 5.53
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 119.20%
- Free cash flow
- -5.96M
- Total cash
- 5.17M
- Total debt
- 10.39M
- Return on equity
- -5955.96%
- Short % of float
- 0.00%
- 50-day average
- 5.70
- 200-day average
- 4.12
Analyst view
Consensus: buy
- Target (low)
- 12.00
- Target (mean)
- 14.67
- Target (high)
- 18.00
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.14.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 25, 2024 | Sep 1, 2024 | -0.05 | -0.16 | -0.11 | -220.00% |
About BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
- Country
- Canada
- Website
- bioharvest.com
News
BioHarvest Sciences (NASDAQ:BHST) & Interparfums (NASDAQ:IPAR) Head to Head Analysis 
BioHarvest Sciences to Report Third Quarter 2026 Financial Results on November 12, 2026 
BioHarvest Sciences' Proprietary Olive Cell Composition Attains Commercial Readiness, Now Available For Licensing And Commercialization 
BioHarvest Sciences Board Authorizes Normal Course Issuer Bid To Repurchase Up To 5% Of Outstanding Common Shares 
Maxim Group Maintains Buy on BioHarvest Sciences, Lowers Price Target to $5 
Roth Capital Maintains Buy on BioHarvest Sciences, Lowers Price Target to $8 - Conference Call:
BioHarvest Sciences Lowers FY2026 Sales Guidance from $42.000M-$48.000M to $37.000M-$40.000M vs $42.914M Est
- BioHarvest Sciences Revises FY26 CDMO Revenue Guidance to $4M-$5M from $4M-$6M; VINIA D2C Revenue Guidance to $33M-$35M from $38M-$42M
BioHarvest Sciences Enters Agreement For A Rare, Endangered Fragrance Plant Cell Culture With A UAE-Based Customer; Sees $20M-$30M In 2027-28 Sales - BioHarvest Sciences Receives $1.4M Grant Approval From Israel Innovation Authority
Your note
Sign in to keep a note on BHST — it syncs with the Stock Master app.